Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Sulfur – selenium or tellurium compound
Reexamination Certificate
2003-10-27
2004-11-02
Vollano, Jean F. (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Sulfur, selenium or tellurium compound
C514S706000, C568S568000, C568S052000, C568S051000, C562S405000, C560S030000
Reexamination Certificate
active
06812257
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to polysubstituted indan-1-ol compounds and their physiologically acceptable salts and physiologically functional derivatives for the prophylaxis or treatment of obesity.
2. Description of the Related Art
WO 97/20806 discloses cyclopentyl-substituted indan-1-ol derivatives as antiinflammatory substances.
SUMMARY OF THE INVENTION
In a preferred embodiment, the invention provides compounds which can be used for reducing weight in mammals and which are suitable for preventing and treating obesity. The instant compounds have a therapeutically utilizable anorectic action.
In another preferred embodiment, the invention also provides a pharmaceutical composition comprising an effective amount of a compound of formula I. The pharmaceutical composition may also comprise one or more active compounds suitable for reducing weight or for the treatment of obesity. The instant composition may also comprise one or more compounds suitable for treatment of other disorders.
In another preferred embodiment, the instant invention provides a method for treating obesity, comprising administering to a subject in need thereof, an effective amount of a compound according to formula I.
In another preferred embodiment, the instant invention provides a method of reducing weight in a mammal, comprising administering to said mammal an effective amount of a compound of formula I.
Additional objects, features and advantages of the invention will be set forth in the description which follows, and in part, will be obvious from the description, or may be learned by practice of the invention. The objects, features and advantages of the invention may be realized and obtained by means of the instrumentalities and combinations particularly pointed out in the appended claims.
REFERENCES:
patent: 6717008 (2004-04-01), Jaehne et al.
patent: 2 345 146 (1976-03-01), None
patent: WO 97 20806 (1997-06-01), None
patent: WO 97/26265 (1997-07-01), None
patent: WO 97/41097 (1997-11-01), None
patent: WO 99/08871 (1998-03-01), None
patent: WO 99/03861 (1999-01-01), None
patent: WO 01/12176 (2001-02-01), None
patent: WO 01 62746 (2001-08-01), None
patent: WO 01 02373 (2002-01-01), None
CA:56:73337 abs of Journal of Organic Chemistry by Oswald 26 pp 3974-80 1961.*
CA:112:35781 abs of Journal of Heterocyclic Chemistry by Trapani et al 26(3) pp 721-4 1989.*
CA:121:9577 abs of Journal of Organometallica Chem. By Cambie et al 467(2) pp 237-44 1994.*
D. Edwards et al., “The Oxidation of Alkyl Sulphides”. J. Chemical Society, 1954, pp 3272-3284.
Lambert, P.D., et al., “Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity.”PNAS, vol. 98, No. 8, Apr. 10, 2001, pp. 4652-4657.
A. V. Sviridova et al., A Method for the Selective Oxidation . . . , Translated fromZhumal Organicheskoi Khimii,, vol. 7, No. 12, pp. 2480-2483, Dec., 1971, original Article submitted Dec. 21, 1970 (translated pages include 2577-2580).
Hugh W. Thompson., “Stereochemical Control of Reductions. The Directive Effect of Carbomethoxy vs. Hydroxymethyl Groups in Catalytic Hydrogenation” The Journal of Organic Chemistry 1971, pp 2577-2581.
Tyle, P., “Iontophoretic Devices for Drug Delivery.”Pharmaceutical Research, vol. 3, No. 6, 1986, pp. 318-326.
Venier, Clifford G., et al., “Peroxytrifluoroacetic Acid. A Convenient Reagent for the Preparation of Sulfoxides and sulfones.”J. Or. Chem., vol. 47, 1982, pp. 3773-3774.
Seebach, Dieter, et al., “Herstellung &agr;-thiolierter Carbonylverbindungen.”Chem. Ber., vol. 109, 1976, pp. 1601-1616.
Bickel Martin
Gossel Matthias
Jaehne Gerhard
Krone Volker
Aventis Pharma Deutschland GmbH
Heller Ehrman White & McAwiffe, LLP
Vollano Jean F.
LandOfFree
Polysubstituted indan-1-ol systems for the prophylaxis or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polysubstituted indan-1-ol systems for the prophylaxis or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polysubstituted indan-1-ol systems for the prophylaxis or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3274819